Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
Thanks to KSquare, I started my investment journey the right way. Their mutual fund options are diverse, affordable, and super easy to manage.
I was impressed by how seamless KSquare’s NRI services are. They handled my documentation with care and helped me invest without unnecessary hassle.
KSquare offers outstanding NFO briefings that help investors understand the market fit. They truly empower clients with knowledge before any commitment.
I enrolled in NPS through KSquare and found their portal extremely intuitive. Their team guided me at every step.
KSquare made it easy to access funds against my mutual investments. The process was fast, smooth, and completely transparent.
I had doubts about NPS before. KSquare explained every detail, making my decision easy. Their support and transparency are unmatched.
Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.
KSquare helped me take my first investment step confidently. I love how easy and flexible their SIP plans are, and the customer care is fantastic.
I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.
As an NRI, I felt disconnected from Indian financial options. KSquare’s services changed that. Everything is efficient and built around my needs.
FAQ's
Frequenlty Asked Question
What is a New Fund Offering (NFO) in mutual funds?
A New Fund Offering is the first-time subscription launch of a new mutual fund scheme by an asset management company.
Are mutual funds suitable for short-term goals?
Debt and liquid funds are ideal for short-term goals, while equity funds are better for long-term wealth creation.
What is the difference between SIP and lump sum in mutual funds?
SIP involves regular, small investments over time, while lump sum is a one-time larger investment. SIP is better for market averaging.
How is the loan amount calculated?
The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.
Is NPS a market-linked investment?
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
Are SIPs better than lump sum investments?
SIPs help average out market volatility over time, making them a safer and more consistent choice than lump sum investing.
Can I set up automatic investments through KSquare?
Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.
Which types of mutual funds are eligible for loans?
Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.